SEC FORM 4
$144,832.58
Stoke Therapeutics, Inc. (STOK)
Sale of 4,525 shares at $32.0072 per share.
Reporting Person Ticho Barry · Officer Title CHIEF MEDICAL OFFICER · Transaction Code S
Traded Aug 18, 2026 · Disclosed Aug 18, 2026
Source: SEC Form 4 · 0001780088-26-000019 · filed 2026-08-18 · View filing →